» Articles » PMID: 10358075

Phosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1999 Jun 8
PMID 10358075
Citations 247
Authors
Affiliations
Soon will be listed here.
Abstract

Protein kinase B lies "downstream" of phosphatidylinositide (PtdIns) 3-kinase and is thought to mediate many of the intracellular actions of insulin and other growth factors. Here we show that FKHR, a human homologue of the DAF16 transcription factor in Caenorhabditis elegans, is rapidly phosphorylated by human protein kinase Balpha (PKBalpha) at Thr-24, Ser-256, and Ser-319 in vitro and at a much faster rate than BAD, which is thought to be a physiological substrate for PKB. The same three sites, which all lie in the canonical PKB consensus sequences (Arg-Xaa-Arg-Xaa-Xaa-(Ser/Thr)), became phosphorylated when FKHR was cotransfected with either PKB or PDK1 (an upstream activator of PKB). All three residues became phosphorylated when 293 cells were stimulated with insulin-like growth factor 1 (IGF-1). The IGF-1-induced phosphorylation was abolished by the PtdIns 3-kinase inhibitor wortmannin but not by PD 98059 (an inhibitor of the mitogen-activated protein kinase cascade) or by rapamycin. These results indicate that FKHR is a physiological substrate of PKB and that it may mediate some of the physiological effects of PKB on gene expression. DAF16 is known to be a component of a signaling pathway that has been partially dissected genetically and includes homologues of the insulin/IGF-1 receptor, PtdIns 3-kinase and PKB. The conservation of Thr-24, Ser-256, and Ser-319 and the sequences surrounding them in DAF16 therefore suggests that DAF16 is also a direct substrate for PKB in C. elegans.

Citing Articles

Elraglusib Induces Cytotoxicity via Direct Microtubule Destabilization Independently of GSK3 Inhibition.

Coats J, Li S, Tanaka T, Tauro S, Sutherland C, Saurin A Cancer Res Commun. 2024; 4(11):3013-3024.

PMID: 39470360 PMC: 11586712. DOI: 10.1158/2767-9764.CRC-24-0408.


Targeting catalase in cancer.

Glorieux C, Buc Calderon P Redox Biol. 2024; 77:103404.

PMID: 39447253 PMC: 11539659. DOI: 10.1016/j.redox.2024.103404.


Effects of phospholipase D1-inhibitory peptide on the growth and metastasis of gastric cancer cells.

Kim D, Yoon M, Lee J, Park S, Han J Mol Cells. 2024; 47(11):100128.

PMID: 39426685 PMC: 11582423. DOI: 10.1016/j.mocell.2024.100128.


Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma.

Willis B, Mongeon K, Dry H, Neveras I, Bryan N, Pandya M Leukemia. 2024; 38(12):2663-2674.

PMID: 39284898 PMC: 11588655. DOI: 10.1038/s41375-024-02401-9.


Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling.

Hwang I, Kim J, Harrison K, Park C, Shi C, Kehrl J Sci Signal. 2024; 17(851):eade1119.

PMID: 39190707 PMC: 11542683. DOI: 10.1126/scisignal.ade1119.